Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CETP | P11597 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | UBE2N | P61088 | 1/20 | 0.50 |
| ▸ | LAP3 | P28838 | 2/20 | 0.45 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11832847 | 1.00 | OPRM1 (0.52) | OPRM1CYP2D6SPHK1LMNATP53 | |
| SCHEMBL14900909 | 1.00 | OPRM1 (0.52) | OPRM1CYP2D6SPHK1LMNATP53 | |
| Hydrochloric Acid SCHEMBL11832535 | 0.97 | OPRM1 (0.50) | OPRM1CYP2D6SPHK1LMNATP53 | |
| Hydrochloric Acid SCHEMBL11826403 | 0.95 | OPRM1 (0.48) | OPRM1CYP2D6SPHK1LMNATP53 | |
| SCHEMBL516405 | 0.95 | OPRM1 (0.52) | OPRM1CYP2D6SPHK1LMNATP53 | |
| SCHEMBL4446153 | 0.92 | OPRM1 (0.50) | OPRM1CYP2D6SPHK1LMNATP53 | |
| Hydrochloric Acid SCHEMBL5604923 | 0.90 | OPRM1 (0.48) | OPRM1CYP2D6SPHK1LMNATP53 | |
| SCHEMBL11134120 | 0.90 | OPRM1 (0.42) | OPRM1CYP2D6SPHK1LMNATP53 | |
| SCHEMBL16649217 | 0.90 | OPRM1 (0.52) | OPRM1CYP2D6SPHK1LMNATP53 | |
| SCHEMBL516727 | 0.90 | OPRM1 (0.52) | OPRM1CYP2D6SPHK1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9340489-B2 | Process for the preparation of deuterated compounds containing N-alkyl groups | SANOFI (FR) | 2016-05-17 | — | — | US | disclosed |
| US-20140081019-A1 | PROCESS FOR THE PREPARATION OF DEUTERATED COMPOUNDS CONTAINING N-ALKYL GROUPS | SANOFI (FR) | 2014-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140081019-A1 | PROCESS FOR THE PREPARATION OF DEUTERATED COMPOUNDS CONTAINING N-ALKYL GROUPS | HDHD5, DRD4, DRD2 | OPRM1 754/4885CYP2D6 540/4885SPHK1 3361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.